NexImmune, Inc.
NEXIDelisted Sep 6, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001538210
NexImmune, Inc. was delisted on Sep 6, 2024; its insiders filed their last Form 4 on Jun 13, 2024; 13 institutions reported holding it in 13F filings for Q2 2024, worth $408.6K in total; no superinvestor held it.
13F holders, Q4 2023
Institutional positions in NexImmune, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 11
- −20 vs. Q3 2023
- Shares held
- 103.5K
- −72.4K (−41.2%) vs. Q3 2023Converted for a 1-for-25 split
- Total value
- $229.4K
- −$692.0K (−75.1%) vs. Q3 2023
- New holders
- 0
- 2 more added
- Sold out
- 20
- 4 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NEXI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 1 | $2.70K |
| Q2 2024 | 13 | $408.6K |
| Q1 2024 | 12 | $858.3K |
| Q4 2023 | 11 | $229.4K |
| Q3 2023 | 31 | $921.4K |
| Q2 2023 | 32 | $1.26M |
| Q1 2023 | 31 | $2.20M |
| Q4 2022 | 29 | $1.45M |
| Q3 2022 | 39 | $4.34M |
| Q2 2022 | 46 | $13.4M |
| Q1 2022 | 52 | $40.1M |
| Q4 2021 | 46 | $47.1M |
| Q3 2021 | 47 | $160.3M |
| Q2 2021 | 42 | $119.0M |
| Q1 2021 | 46 | $184.9M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding NexImmune, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 1 | $2 | 0.00% | −1−49.0% | ReducedConverted for a 1-for-25 split |
| Wells Fargo & Company | 5 | $11 | 0.00% | −0−0.8% | ReducedConverted for a 1-for-25 split |
| BlackRock Inc. | 14 | $31 | 0.00% | −0−2.8% | ReducedConverted for a 1-for-25 split |
| Morgan Stanley | 17 | $38 | 0.00% | −1−4.7% | ReducedConverted for a 1-for-25 split |
| Royal Bank of Canada | 1,047 | $2.00K | 0.00% | +1,025+4,590.9% | AddedConverted for a 1-for-25 split |
| Tower Research Capital LLC (TRC) | 1,801 | $4.00K | 0.00% | +1,545+604.6% | AddedConverted for a 1-for-25 split |
| Comerica Bank | 3,256 | $7.23K | 0.00% | 00.0% | UnchangedConverted for a 1-for-25 split |
| The PNC Financial Services Group, Inc. | 12,640 | $28.1K | 0.00% | 00.0% | UnchangedConverted for a 1-for-25 split |
| EPIQ Capital Group, LLC | 15,624 | $34.7K | 0.02% | 00.0% | UnchangedConverted for a 1-for-25 split |
| Adage Capital Partners GP, L.L.C. | 32,054 | $71.2K | 0.00% | 00.0% | UnchangedConverted for a 1-for-25 split |
| Slate Path Capital LP | 36,999 | $82.1K | 0.00% | 00.0% | UnchangedConverted for a 1-for-25 split |
| Allen Operations LLC | 0 | $0 | 0.00% | −25,437−100.0% | Sold outConverted for a 1-for-25 split |
| Raymond James & Associates | 0 | $0 | 0.00% | −12,825−100.0% | Sold outConverted for a 1-for-25 split |
| First Manhattan Co | 0 | $0 | 0.00% | −5,964−100.0% | Sold outConverted for a 1-for-25 split |
| M28 Capital Management LP | 0 | $0 | 0.00% | −5,338−100.0% | Sold outConverted for a 1-for-25 split |
| CAPROCK Group, Inc. | 0 | $0 | 0.00% | −4,139−100.0% | Sold outConverted for a 1-for-25 split |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −4,326−100.0% | Sold outConverted for a 1-for-25 split |
| Vanguard Group Inc | 0 | $0 | 0.00% | −3,893−100.0% | Sold outConverted for a 1-for-25 split |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −2,620−100.0% | Sold outConverted for a 1-for-25 split |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold outConverted for a 1-for-25 split |
| Millennium Management LLC | 0 | $0 | 0.00% | −1,866−100.0% | Sold outConverted for a 1-for-25 split |
| Bank of Montreal | 0 | $0 | 0.00% | −1,280−100.0% | Sold outConverted for a 1-for-25 split |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −1,417−100.0% | Sold outConverted for a 1-for-25 split |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −874−100.0% | Sold outConverted for a 1-for-25 split |
| State Street Corp | 0 | $0 | 0.00% | −917−100.0% | Sold outConverted for a 1-for-25 split |
| Baader Bank INC | 0 | $0 | 0.00% | −690−100.0% | Sold outConverted for a 1-for-25 split |
| Northern Trust Corp | 0 | $0 | 0.00% | −507−100.0% | Sold outConverted for a 1-for-25 split |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −403−100.0% | Sold outConverted for a 1-for-25 split |
| Smith, Salley & Associates | 0 | $0 | 0.00% | −400−100.0% | Sold outConverted for a 1-for-25 split |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −40−100.0% | Sold outConverted for a 1-for-25 split |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −0−100.0% | Sold outConverted for a 1-for-25 split |